{"protocolSection":{"identificationModule":{"nctId":"NCT00166517","orgStudyIdInfo":{"id":"V260-013"},"secondaryIdInfos":[{"id":"2005_071"}],"organization":{"fullName":"Merck Sharp & Dohme LLC","class":"INDUSTRY"},"briefTitle":"V260 Registration Study (V260-013)(COMPLETED)","officialTitle":"Immunogenicity and Safety of V260 in Healthy Infants in Korea"},"statusModule":{"statusVerifiedDate":"2015-03","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2005-08"},"primaryCompletionDateStruct":{"date":"2006-07","type":"ACTUAL"},"completionDateStruct":{"date":"2006-07","type":"ACTUAL"},"studyFirstSubmitDate":"2005-09-09","studyFirstSubmitQcDate":"2005-09-09","studyFirstPostDateStruct":{"date":"2005-09-14","type":"ESTIMATED"},"resultsFirstSubmitDate":"2009-07-06","resultsFirstSubmitQcDate":"2009-08-13","resultsFirstPostDateStruct":{"date":"2009-09-23","type":"ESTIMATED"},"lastUpdateSubmitDate":"2015-03-12","lastUpdatePostDateStruct":{"date":"2015-04-01","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Merck Sharp & Dohme LLC","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"Immunogenicity and Safety of V260 in Healthy Infants in Korea"},"conditionsModule":{"conditions":["Rotavirus"],"keywords":["Gastrointestinal Rotavirus"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE3"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","INVESTIGATOR"]}},"enrollmentInfo":{"count":178,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"1","type":"EXPERIMENTAL","description":"RotaTeq","interventionNames":["Biological: Rotavirus Vaccine, Live, Oral, Pentavalent"]},{"label":"2","type":"PLACEBO_COMPARATOR","description":"Placebo","interventionNames":["Biological: Comparator: Placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"Rotavirus Vaccine, Live, Oral, Pentavalent","description":"3 doses of rotavirus vaccine live, oral, pentavalent on Day 1, 28 to 70 days post Dose 1, and 28 to 70 days post Dose 2","armGroupLabels":["1"]},{"type":"BIOLOGICAL","name":"Comparator: Placebo","description":"3 doses of placebo to rotavirus vaccine live, oral, pentavalent on Day 1, 28 to 70 days post Dose 1, and 28 to 70 days post Dose 2","armGroupLabels":["2"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Serum Anti-Rotavirus IgA Response","description":"Number of subjects with ≥ 3-fold rise from baseline (Predose 1) in\n\nSerum IgA 14 days Postdose 3","timeFrame":"Baseline and 14 days Postdose 3"}],"secondaryOutcomes":[{"measure":"Serum Neutralizing Antibody (SNA) Response to Serotypes G1, G2, G3, G4 and P1A","description":"Number of subjects with ≥ 3-fold rise from baseline (Predose 1) in\n\nSNA response to G1, G2, G3, G4 and P1A 14 days Postdose 3","timeFrame":"Baseline and 14 days Postdose 3"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* At first study vaccination, age 6 weeks through exactly 12 weeks\n\nExclusion Criteria:\n\n* History of congenital abdominal disorders, intussusception, or abdominal surgery\n* History of known prior rotavirus disease\n* Ongoing chronic diarrhea or failure to thrive\n* Clinical evidence of active gastrointestinal illness","healthyVolunteers":true,"sex":"ALL","minimumAge":"6 Weeks","maximumAge":"12 Weeks","stdAges":["CHILD"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Medical Monitor","affiliation":"Merck Sharp & Dohme LLC","role":"STUDY_DIRECTOR"}]},"referencesModule":{"references":[{"pmid":"18174862","type":"RESULT","citation":"Kim DS, Lee TJ, Kang JH, Kim JH, Lee JH, Ma SH, Kim SY, Kim HM, Shin SM. Immunogenicity and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy infants in Korea. Pediatr Infect Dis J. 2008 Feb;27(2):177-8. doi: 10.1097/INF.0b013e31815aba79."}]}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"Subjects with history of congenital abdominal disorders, intussusception, or abdominal surgery; history of\n\nknown prior rotavirus disease; ongoing chronic diarrhea or failure to thrive and those with clinical evidence\n\nof active gastrointestinal illness were excluded.","recruitmentDetails":"The study was conducted at 8 sites.in Korea from 02-Aug-2005 (first patient in) to 25-May-2006 (last dose\n\ngiven). Last subject completed follow-up: 05-Jul-2006. All data corrections applied (Frozen File) on 18-\n\nAug-2006","groups":[{"id":"FG000","title":"RotaTeq™","description":"Three oral doses of RotaTeq™ (rotavirus vaccine, live, oral, pentavalent) administered 28 to 70 days apart, with up to 42 days of safety follow-up after each vaccination."},{"id":"FG001","title":"Placebo","description":"Placebo matching RotaTeq™ administered 28 to 70 days apart, with up to 42 days of safety follow-up after each vaccination."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"115"},{"groupId":"FG001","numSubjects":"63"}]},{"type":"Vaccinated at Visit 1","achievements":[{"groupId":"FG000","numSubjects":"115"},{"groupId":"FG001","numSubjects":"63"}]},{"type":"Vaccinated at Visit 2","achievements":[{"groupId":"FG000","numSubjects":"112"},{"groupId":"FG001","numSubjects":"61"}]},{"type":"Vaccinated at Visit 3","achievements":[{"groupId":"FG000","numSubjects":"110"},{"groupId":"FG001","numSubjects":"61"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"110"},{"groupId":"FG001","numSubjects":"61"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"2"}]}],"dropWithdraws":[{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"1"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"RotaTeq™","description":"Three oral doses of RotaTeq™ (rotavirus vaccine, live, oral, pentavalent) administered 28 to 70 days apart, with up to 42 days of safety follow-up after each vaccination."},{"id":"BG001","title":"Placebo","description":"Placebo matching RotaTeq™ administered 28 to 70 days apart, with up to 42 days of safety follow-up after each vaccination."},{"id":"BG002","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"115"},{"groupId":"BG001","value":"63"},{"groupId":"BG002","value":"178"}]}],"measures":[{"title":"Age, Customized","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"6-12 Weeks of Age","categories":[{"measurements":[{"groupId":"BG000","value":"114"},{"groupId":"BG001","value":"63"},{"groupId":"BG002","value":"177"}]}]},{"title":"Over 12 Weeks of Age","categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"46"},{"groupId":"BG001","value":"30"},{"groupId":"BG002","value":"76"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"69"},{"groupId":"BG001","value":"33"},{"groupId":"BG002","value":"102"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Serum Anti-Rotavirus IgA Response","description":"Number of subjects with ≥ 3-fold rise from baseline (Predose 1) in\n\nSerum IgA 14 days Postdose 3","populationDescription":"Per Protocol Population","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"Baseline and 14 days Postdose 3","groups":[{"id":"OG000","title":"RotaTeq™","description":"Three oral doses of RotaTeq™ (rotavirus vaccine, live, oral, pentavalent) administered 28 to 70 days apart, with up to 42 days of safety follow-up after each vaccination."},{"id":"OG001","title":"Placebo","description":"Placebo matching RotaTeq™ administered 28 to 70 days apart, with up to 42 days of safety follow-up after each vaccination."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"94"},{"groupId":"OG001","value":"52"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"89"},{"groupId":"OG001","value":"7"}]}]}],"analyses":[{"groupIds":["OG000"],"testedNonInferiority":true,"nonInferiorityType":"NON_INFERIORITY_OR_EQUIVALENCE","nonInferiorityComment":"Non-inferiority was assessed versus a constant, 85%, based on historical data.","pValue":"0.003","pValueComment":"p ≥.85, where p is the proportion of subjects who achieved ≥3-fold rise from baseline in the group that received RotaTeq®","statisticalMethod":"Exact test of proportion","statisticalComment":"Exact test of proportion, based on binomial distribution","ciPctValue":"95"}]},{"type":"SECONDARY","title":"Serum Neutralizing Antibody (SNA) Response to Serotypes G1, G2, G3, G4 and P1A","description":"Number of subjects with ≥ 3-fold rise from baseline (Predose 1) in\n\nSNA response to G1, G2, G3, G4 and P1A 14 days Postdose 3","populationDescription":"Per Protocol Population","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"Baseline and 14 days Postdose 3","groups":[{"id":"OG000","title":"RotaTeq™","description":"Three oral doses of RotaTeq™ (rotavirus vaccine, live, oral, pentavalent) administered 28 to 70 days apart, with up to 42 days of safety follow-up after each vaccination."},{"id":"OG001","title":"Placebo","description":"Placebo matching RotaTeq™ administered 28 to 70 days apart, with up to 42 days of safety follow-up after each vaccination."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"94"},{"groupId":"OG001","value":"52"}]}],"classes":[{"title":"Number of subjects with ≥ 3-fold rise in SNA to G1","categories":[{"measurements":[{"groupId":"OG000","value":"67"},{"groupId":"OG001","value":"2"}]}]},{"title":"Number of subjects with ≥ 3-fold rise in SNA to G2","categories":[{"measurements":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"1"}]}]},{"title":"Number of subjects with ≥ 3-fold rise in SNA to G3","categories":[{"measurements":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"1"}]}]},{"title":"Number of subjects with ≥ 3-fold rise in SNA to G4","categories":[{"measurements":[{"groupId":"OG000","value":"62"},{"groupId":"OG001","value":"4"}]}]},{"title":"Number of subjects with ≥3-fold rise in SNA to P1A","categories":[{"measurements":[{"groupId":"OG000","value":"65"},{"groupId":"OG001","value":"3"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"Patients in this study were followed for all adverse experiences, for 42 days following each study vaccination.","description":"The number of patients listed in the Adverse Event tables (RotaTeq™ and Placebo) is the number of patients who received study treatment.\n\nAlthough a patient may have had two or more clinical adverse experiences the patient is counted only once in a category. The same patient may appear in different categories.","eventGroups":[{"id":"EG000","title":"RotaTeq™","description":"Three oral doses of RotaTeq™ (rotavirus vaccine, live, oral, pentavalent) administered 28 to 70 days apart, with up to 42 days of safety follow-up after each vaccination.","seriousNumAffected":6,"seriousNumAtRisk":114,"otherNumAffected":110,"otherNumAtRisk":114},{"id":"EG001","title":"Placebo","description":"Placebo matching RotaTeq™ administered 28 to 70 days apart, with up to 42 days of safety follow-up after each vaccination.","seriousNumAffected":7,"seriousNumAtRisk":63,"otherNumAffected":63,"otherNumAtRisk":63}],"seriousEvents":[{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Acute bronchiolitis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Bronchiolitis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Bronchopneumonia","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Otitis media acute","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":2,"numAtRisk":63}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Pneumonia mycoplasmal","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Burn","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]}],"otherEvents":[{"term":"Acute tonsillopharyngitis","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Acute tonsillopharyngitis mild","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Laryngomalacia","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Conjunctival injection","organSystem":"Eye disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Conjunctivitis","organSystem":"Eye disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":114},{"groupId":"EG001","numAffected":2,"numAtRisk":63}]},{"term":"Eye discharge","organSystem":"Eye disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Eye disorders","organSystem":"Eye disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Strabismus","organSystem":"Eye disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Anal fissure","organSystem":"Gastrointestinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":5,"numAtRisk":114},{"groupId":"EG001","numAffected":4,"numAtRisk":63}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":59,"numAtRisk":114},{"groupId":"EG001","numAffected":34,"numAtRisk":63}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Loose stools","organSystem":"Gastrointestinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":114},{"groupId":"EG001","numAffected":3,"numAtRisk":63}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":65,"numAtRisk":114},{"groupId":"EG001","numAffected":33,"numAtRisk":63}]},{"term":"Fever","organSystem":"General disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":25,"numAtRisk":114},{"groupId":"EG001","numAffected":17,"numAtRisk":63}]},{"term":"Irritability","organSystem":"General disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":97,"numAtRisk":114},{"groupId":"EG001","numAffected":52,"numAtRisk":63}]},{"term":"Atopy","organSystem":"Immune system disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":114},{"groupId":"EG001","numAffected":2,"numAtRisk":63}]},{"term":"Acute bronchiolitis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Acute pharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":114},{"groupId":"EG001","numAffected":5,"numAtRisk":63}]},{"term":"Bronchiolitis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":114},{"groupId":"EG001","numAffected":5,"numAtRisk":63}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":114},{"groupId":"EG001","numAffected":3,"numAtRisk":63}]},{"term":"Chickenpox","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Cold","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":114},{"groupId":"EG001","numAffected":4,"numAtRisk":63}]},{"term":"Croup","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Enteritis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Enterovirus infection","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Folliculitis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":13,"numAtRisk":114},{"groupId":"EG001","numAffected":4,"numAtRisk":63}]},{"term":"Impetigo","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Oral candidiasis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Otitis externa","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Otitis media","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Otitis media acute","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Perianal abscess","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Pharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Rhinitis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Skin infection","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":44,"numAtRisk":114},{"groupId":"EG001","numAffected":36,"numAtRisk":63}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Scratch","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Oral intake reduced","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Musculoskeletal disorder","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Fear","organSystem":"Psychiatric disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Food aversion","organSystem":"Psychiatric disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Dysuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":114},{"groupId":"EG001","numAffected":3,"numAtRisk":63}]},{"term":"Nasal obstruction","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Nasal stuffiness","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Rhinorrhoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":114},{"groupId":"EG001","numAffected":2,"numAtRisk":63}]},{"term":"Dermatitis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Dermatitis atopic","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":9,"numAtRisk":114},{"groupId":"EG001","numAffected":6,"numAtRisk":63}]},{"term":"Dermatitis contact","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Dermatitis diaper","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Diaper rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":114},{"groupId":"EG001","numAffected":2,"numAtRisk":63}]},{"term":"Facial rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Miliaria","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Skin rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":114},{"groupId":"EG001","numAffected":1,"numAtRisk":63}]},{"term":"Urticaria","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]},{"term":"Vesicle","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"WHOART92","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":114},{"groupId":"EG001","numAffected":0,"numAtRisk":63}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."},"pointOfContact":{"title":"Senior Vice President,Global Clinical Development","organization":"Merck Sharp & Dohme Corp.","email":"ClinicalTrialsDisclosure@merck.com","phone":"1-800-672-6372"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09","removedCountries":["South Korea"]},"interventionBrowseModule":{"meshes":[{"id":"D022243","term":"Rotavirus Vaccines"}],"ancestors":[{"id":"D014765","term":"Viral Vaccines"},{"id":"D014612","term":"Vaccines"},{"id":"D001688","term":"Biological Products"},{"id":"D045424","term":"Complex Mixtures"}]}},"hasResults":true}